Lunai Bioworks Inc. Option Indexed to Issuer's Equity, Strike Price
Lunai Bioworks Inc. (LNAI) reported Option Indexed to Issuer's Equity, Strike Price of $3.92 per share for the 1-month period ending 2021-03-31, per its 10-Q filed 2021-05-17.
Discontinued › Notes › Other Liabilities
us-gaap:OptionIndexedToIssuersEquityStrikePrice1 · last filed 2021-09-24
- Lunai Bioworks Inc. option indexed to issuer's equity, strike price for fiscal 2020 was $2.00, a 0.00% change from fiscal 2019.
- Lunai Bioworks Inc. option indexed to issuer's equity, strike price for fiscal 2019 was $2.00.
| Period end | Option Indexed to Issuer's Equity, Strike Price 0 month | Option Indexed to Issuer's Equity, Strike Price 1 month | Option Indexed to Issuer's Equity, Strike Price 12 month |
|---|---|---|---|
| 2021-03-31 | $3.92 10-Q · filed 2021-05-17 | ||
| 2021-03-18 | $3.92 10-Q · filed 2021-05-17 | ||
| 2020-12-14 | $1.30 10-Q · filed 2021-05-17 | ||
| 2020-06-30 | $2.00 10-K · filed 2021-09-24 | ||
| 2019-06-30 | $2.00 10-K · filed 2019-09-30 | ||
| 2019-06-27 | $1.30 10-K · filed 2020-09-23 | ||
| 2018-12-27 | $1.30 10-K · filed 2020-09-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |